Separation Anxiety (cont.)
Roxanne Dryden-Edwards, MD
Dr. Roxanne Dryden-Edwards is an adult, child, and adolescent psychiatrist. She is a former Chair of the Committee on Developmental Disabilities for the American Psychiatric Association, Assistant Professor of Psychiatry at Johns Hopkins Hospital in Baltimore, Maryland, and Medical Director of the National Center for Children and Families in Bethesda, Maryland.
Melissa Conrad Stöppler, MD
Melissa Conrad Stöppler, MD, is a U.S. board-certified Anatomic Pathologist with subspecialty training in the fields of Experimental and Molecular Pathology. Dr. Stöppler's educational background includes a BA with Highest Distinction from the University of Virginia and an MD from the University of North Carolina. She completed residency training in Anatomic Pathology at Georgetown University followed by subspecialty fellowship training in molecular diagnostics and experimental pathology.
In this Article
- What is separation anxiety disorder?
- What are the symptoms and signs of separation anxiety disorder?
- What are causes and risk factors for separation anxiety disorder?
- How is separation anxiety disorder diagnosed?
- What is the treatment for separation anxiety disorder?
- What happens if separation anxiety disorder is left untreated?
- Where can I find more information on separation anxiety disorder?
- Separation Anxiety Disorder At A Glance
Separation Anxiety Disorder At A Glance
- Infants show stranger anxiety by crying when someone unfamiliar approaches. It is a normal stage of development that usually starts at about 8 months of age and abates by 2 years of age.
- Separation anxiety as a normal life stage first develops at about 7 months of age, once object permanence has been established. It is at its strongest at 10-18 months of age and usually subsides by 3 years of age.
- Separation anxiety disorder begins in childhood and is characterized by worrying out of proportion to the situation of temporarily leaving home or otherwise separating from loved ones.
- Approximately 4%-5% of children and adolescents suffer from separation anxiety disorder.
- Examples of separation anxiety disorder symptoms include school refusal or school phobia, resistance to going to bed at night, and physical complaints in reaction to actual or anticipated separation from primary caretakers.
- Professionals trained and experienced in assessing mental health in children will likely interview the child and parents separately and ask about symptoms of anxiety, screen for other mental-health conditions, and recommend the child receive a full medical evaluation.
- Separation anxiety disorder is likely caused by the combination of genetic and environmental vulnerabilities. Risk factors include low socioeconomic status, family histories of anxiety, and mothers who were stressed during pregnancy.
- A majority of children with separation anxiety disorder have school refusal as a symptom. Up to 80% of children who refuse school qualify for a diagnosis of separation anxiety disorder.
- Counseling is usually considered the best treatment method compared to medications. Types of counseling used to treat separation anxiety disorder include behavioral, cognitive, and individual psychotherapies, as well as parent counseling and guiding teachers on how to help the child.
- SSRIs like fluvoxamine are considered the safest and most effective medications to treat separation anxiety disorder, followed by tricyclic antidepressants (TCAs), with benzodiazepines as a last resort.
- Children with separation anxiety disorder are at higher risk for developing other mental-health problems, particularly anxiety disorders.
American Academy of Child and Adolescent Psychiatry. "Practice Parameter for the Assessment and Treatment of Children and Adolescents With Anxiety Disorders." Journal of the American Academy of Child and Adolescent Psychiatry 46.2 (2007): 267-283.
American Academy of Pediatrics. "Separation Anxiety Disorder: Planning Treatment." Pediatrics in Review 21 (2000): 248.
den Boer, J.A. "Social Phobia: Epidemiology, Recognition and Treatment." British Medical Journal 315 (1997): 796-800.
Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Treatment Revision. American Psychiatric Association: Washington, D.C., 2000.
Foley, D.L., D.B. Goldston, E.J. Costello, and A. Angold. "Proximal Psychiatric Risk Factors for Suicidality in Youth." Archives of General Psychiatry 63 (2006): 1017-1024.
Foley, D., M. Rutter, A. Pickles, A. Angold, M. Hermine, J. Silberg, and L. Eaves. "Informant Disagreement for Separation Anxiety Disorder." Journal of the American Academy of Child and Adolescent Psychiatry 43.4 Apr. 2004: 452-460.
Fremont, W.P. "School Refusal in Children and Adolescents." American Family Physician Oct. 15, 2003.
Lewinsohn, P.M., J.M. Holm-Denoma, J.W. Small, J.R. Seeley, and T.E. Joiner. "Separation Anxiety Disorder in Childhood as a Risk Factor for Future Mental Illness." Journal of the American Academy of Child and Adolescent Psychiatry 47.5 May 2008: 548-555.
Masi, G., M. Mucci, and S. Millepiedi. "Separation Anxiety Disorder in Children and Adolescents: Epidemiology, Diagnosis and Management." CNS Drugs 15.2 (2001): 93-104.
National Institute of Mental Health. "Behavioral Therapy Effectively Treats Children With Social Phobia." Dec. 17, 2007.
Osone, A., and S. Takahashi. "Possible Link Between Childhood Separation Anxiety and Adulthood Personality Disorder in Patients With Anxiety Disorders in Japan." Journal of Clinical Psychiatry 67.9 Sept. 2006: 1451-1457.
Physicians' Desk Reference Staff. Physicians' Desk Reference, 62 ed. Blackwell Publishing: Oxford, United Kingdom, 2008.
Talge, N.M., C. Neal, and V. Glover. "Antenatal Maternal Stress and Long-Term Effects on Child Neurodevelopment: How and Why?" Journal of Child Psychology and Psychiatry 48.3-4 Mar. 7, 2007: 245-261.
van der Linden, G.J., D.J. Stein, and A.J. van Balkom. "The Efficacy of the Selective Serotonin Reuptake Inhibitors for Social Anxiety Disorder (Social Phobia): A Meta-Analysis of Randomized Controlled Trials." International Clinical Psychopharmacology 15.2 Aug. 2000: S15-S23.
Walkup, J.T., M.J. Labellarte, M.A. Riddle, D.S. Pine, L. Greenhill, R. Klein, et al. "Fluvoxamine for the Treatment of Anxiety Disorders in Children and Adolescents." New England Journal of Medicine 344.17 Apr. 26, 2001: 1279-1285.
Last Editorial Review: 8/20/2010
Viewers share their comments
- Submit »
- Submit »
Get tips on therapy and treatment.